查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1452937

全球心律不整監測設備市場 2024-2031

Global Cardiac Arrhythmia Monitoring Devices Market 2024-2031
出版日期: | 出版商: Orion Market Research | 英文 225 Pages | 商品交期: 2-3個工作天內

價格

預計全球心律不整監測設備市場在預測期內將以 7.5% 的CAGR成長。全球心房顫動（AF）發病率和盛行率不斷上升，推動了對心律不整監測設備的需求，從而推動了全球市場的成長。光是在美國，就有300 至600 萬人患有房顫，預計到2050 年這一數字將達到約600 至1600 萬。在歐洲，2010 年55 歲以上人群中房顫患病率約為900 萬，預計將達到 2060 年，這一數字將達到 1400 萬。據估計，到 2050 年，亞洲至少將有 7200 萬人被診斷出房顫，其中約 300 萬人患有房顫相關中風。老年族群罹患心房顫動的風險很高。根據世界衛生組織2021年10月報告，全球60歲及以上人口預計將從2020年的10億增加到2050年的21億，預計將對家居需求產生重大影響由於老年人更加依賴他人來滿足他們的護理和其他需求，因此醫療保健軟體市場變得更加重要。

不斷成長的老年人口進一步滿足了全球市場的需求。 2024 年 1 月，來自立陶宛兩所大學的研究人員開發了一種病患安全監測技術，用於識別和管理引發心房顫動的個人因素。該技術是考納斯理工大學生物醫學工程研究所 (KTU BMEI) 和維爾紐斯大學 (VU) Santaros Clinics 合作的成果。心房顫動監測設備領域正在進行的研究進一步促進了市場的發展。攜帶式且易於監控的設備的開發預計將為全球市場的成長提供有利可圖的機會。監控設備的高成本可能會限制其市場成長。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 按細分
    • 按地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • Abbott Laboratories
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • ACSDiagnostics
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • GE Healthcare
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Koninklijke Philips NV
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場細分

  • 按設備類型分類的全球心律不整監測設備市場
    • 事件監控設備
    • 連續節律監測設備
    • 動態心電圖監測設備
  • 按服務提供者分類的全球心律不整監測設備市場
    • 行動心臟遙測監測服務供應商
    • 獨立診斷測試設施/診所

第 5 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 6 章：公司簡介

  • AliveCor Inc.
  • Applied Cardiac Systems
  • Biotricity
  • Biotronik
  • BPL Medical Technologies
  • Fukuda Denshi Co. Ltd.
  • HD Medical Inc.
  • HemoCath Ltd.
  • iRhythm Technologies Inc.
  • Medi-Lynx Cardiac Monitoring LLC
  • Medtronic PLC
  • Moving Analytics Inc.
  • Nihon Kohden Corp.
  • Progetti SRL
  • SpaceLabs Healthcare (OSI Systems, Inc.)
  • Spacelabs Healthcare Inc.
  • Welch Allyn, Inc.
Product Code: OMR2028130

Global Cardiac Arrhythmia Monitoring Devices Market Size, Share & Trends Analysis Report by Device Type (Event Monitoring Devices, Continuous Rhythm Monitoring Devices, and Holter Monitoring Devices), and by Service Provider (Mobile Cardiac Telemetry Monitoring Service Providers, Independent Diagnostic Testing Facilities/Clinics) Forecast Period (2024-2031)

The global cardiac arrhythmia monitoring devices market is anticipated to grow at a considerable CAGR of 7.5% during the forecast period. The growing incidence and prevalence of atrial fibrillation (AF) globally has driven the demand for cardiac arrhythmia monitoring devices thereby driving the global market growth. In the US alone, 3 to 6 million people have AF, and the numbers are projected to reach approximately 6 to 16 million by 2050. In Europe, prevalent AF in 2010 was approximately 9 million among individuals older than 55 years and is expected to reach 14 million by 2060. It was estimated that by 2050 AF will be diagnosed at least in 72 million individuals in Asia, with approximately 3 million with AF-related strokes. The geriatric population is highly at risk of having AF. According to the October 2021 report of the World Health Organization, the global population of people aged 60 years and more is expected to increase from 1 billion in 2020 to 2.1 billion by 2050, which is expected to have a significant impact on the demand for home healthcare software market as older people are more dependent upon others for their care and other needs.

The growing geriatric population is further aiding to the demand for the global market. In January 2024, researchers from two Lithuanian universities have developed a patient-safe monitoring technology to identify and manage individual factors provoking atrial fibrillation. The technology is a result of a collaboration between Kaunas University of Technology Biomedical Engineering Institute (KTU BMEI) and Vilnius University (VU) Santaros Clinics. The ongoing researches in the field of AF monitoring devices are further aiding to the market development. The development of portable and easy to monitoring devices is anticipated to offer lucrative opportunities to the growth of the global market. The high cost of monitoring device may restrain their market growth.

Segmental Outlook

The global cardiac arrhythmia monitoring devices market is segmented based on device type, and service provider. Based on device type, the market is segmented into event monitoring devices, continuous rhythm monitoring devices, and Holter monitoring devices. Based on service providers, the market is segmented into mobile cardiac telemetry monitoring service providers, and independent diagnostic testing facilities/clinics.

Holter Monitoring Devices Anticipated to Exhibit Considerable Growth in the Global Cardiac Arrhythmia Monitoring Devices Market

The ability of these devices to be used for longer durations in diagnosing sporadic symptoms among patients is a key contributor to its growing market demand. They also offer faster and more convenient monitoring to increase patient compliance and enhance treatment outcomes. New product launches in this category are further aiding the growth of this market segment. For instance, in February 2021, RhythMedix launched a wearable cardiac monitor for arrhythmia detection. RhythMedix stated that the one-piece device is the first wearable multi-modality cardiac monitor offering Holter monitoring and connecting patients and clinicians for better patient care.

Regional Outlook

The global cardiac arrhythmia monitoring devices market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Asia-Pacific is anticipated to exhibit considerable growth in the global market.

North America Held a Major Share in the Global Market

The regional market share is attributed to the high prevalence of arrhythmia and the availability of advanced healthcare infrastructure. Atrial fibrillation, often called AFib or AF, is the most common type of treated heart arrhythmia. According to the Centers for Disease Control & Prevention, in 2019, 183,321 mortalities occurred in the US due to AFib. It is estimated that 12.1 million people in the US will have AFib in 2030. The easy availability of advanced monitoring devices along with high healthcare expenditure is further contributing to the regional market share.

Market Players Outlook

The major companies serving the global cardiac arrhythmia monitoring devices market include Abbott Laboratories, Medtronic PLC, ACSDiangostics, GE Healthcare, and Koninklijke Philips NV among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and advancement in their product offerings to stay competitive in the market. For instance, in October 2023, Boston Scientific received FDA clearance and launched its next-generation insertable cardiac monitor for long-term monitoring of arrhythmias associated with atrial fibrillation, cryptogenic stroke, and syncope. The system (LUX-Dx II+) is designed with algorithms to detect and verify arrhythmias before sending an alert to clinicians and allows patient care teams to adjust event detection settings remotely and record symptoms without in-person visits, according to a company email sent to Healio.

The Report Covers:

  • Market value data analysis of 2023 and forecast to 2031.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global cardiac arrhythmia monitoring devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1.Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1.Research Methods and Tools
  • 1.2.Market Breakdown
    • 1.2.1.By Segments
    • 1.2.2.By Region

2.Market Overview and Insights

  • 2.1.Scope of the Report
  • 2.2.Analyst Insight & Current Market Trends
    • 2.2.1.Key Findings
    • 2.2.2.Recommendations
    • 2.2.3.Conclusion

3.Competitive Landscape

  • 3.1.Key Company Analysis
  • 3.2.Abbott Laboratories
    • 3.2.1.Overview
    • 3.2.2.Financial Analysis
    • 3.2.3.SWOT Analysis
    • 3.2.4.Recent Developments
  • 3.3.ACSDiagnostics
    • 3.3.1.Overview
    • 3.3.2.Financial Analysis
    • 3.3.3.SWOT Analysis
    • 3.3.4.Recent Developments
  • 3.4.GE Healthcare
    • 3.4.1.Overview
    • 3.4.2.Financial Analysis
    • 3.4.3.SWOT Analysis
    • 3.4.4.Recent Developments
  • 3.5.Koninklijke Philips NV
    • 3.5.1.Overview
    • 3.5.2.Financial Analysis
    • 3.5.3.SWOT Analysis
    • 3.5.4.Recent Developments
  • 3.6.Key Strategy Analysis

4.Market Segmentation

  • 4.1.Global Cardiac Arrhythmia Monitoring Devices Market by Device Type
    • 4.1.1.Event Monitoring Devices
    • 4.1.2.Continuous Rhythm Monitoring Devices
    • 4.1.3.Holter Monitoring Devices
  • 4.2.Global Cardiac Arrhythmia Monitoring Devices Market by Service Provider
    • 4.2.1.Mobile Cardiac Telemetry Monitoring Service Providers
    • 4.2.2.Independent Diagnostic Testing Facilities/Clinics

5.Regional Analysis

  • 5.1.North America
    • 5.1.1.United States
    • 5.1.2.Canada
  • 5.2.Europe
    • 5.2.1.UK
    • 5.2.2.Germany
    • 5.2.3.Italy
    • 5.2.4.Spain
    • 5.2.5.France
    • 5.2.6.Rest of Europe
  • 5.3.Asia-Pacific
    • 5.3.1.China
    • 5.3.2.India
    • 5.3.3.Japan
    • 5.3.4.South Korea
    • 5.3.5.Rest of Asia-Pacific
  • 5.4.Rest of the World

6.Company Profiles

  • 6.1.AliveCor Inc.
  • 6.2.Applied Cardiac Systems
  • 6.3.Biotricity
  • 6.4.Biotronik
  • 6.5.BPL Medical Technologies
  • 6.6.Fukuda Denshi Co. Ltd.
  • 6.7.HD Medical Inc.
  • 6.8.HemoCath Ltd.
  • 6.9.iRhythm Technologies Inc.
  • 6.10.Medi-Lynx Cardiac Monitoring LLC
  • 6.11.Medtronic PLC
  • 6.12.Moving Analytics Inc.
  • 6.13.Nihon Kohden Corp.
  • 6.14.Progetti SRL
  • 6.15.SpaceLabs Healthcare (OSI Systems, Inc.)
  • 6.16.Spacelabs Healthcare Inc.
  • 6.17.Welch Allyn, Inc.

LIST OF TABLES

  • 1.GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2023-2031 ($ MILLION)
  • 2.GLOBAL EVENT MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 3.GLOBAL CONTINUOUS RHYTHM MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 4.GLOBAL HOLTER MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 5.GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY SERVICE PROVIDER, 2023-2031 ($ MILLION)
  • 6.GLOBAL MOBILE CARDIAC TELEMETRY MONITORING SERVICE PROVIDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 7.GLOBAL INDEPENDENT DIAGNOSTIC TESTING FACILITIES/CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 8.GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
  • 9.NORTH AMERICAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 10.NORTH AMERICAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2023-2031 ($ MILLION)
  • 11.NORTH AMERICAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY SERVICE PROVIDER, 2023-2031 ($ MILLION)
  • 12.EUROPEAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 13. EUROPEAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2023-2031 ($ MILLION)
  • 14.EUROPEAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY SERVICE PROVIDER, 2023-2031 ($ MILLION)
  • 15.ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 16.ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2023-2031 ($ MILLION)
  • 17.ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY SERVICE PROVIDER, 2023-2031 ($ MILLION)
  • 18.REST OF THE WORLD CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
  • 19.REST OF THE WORLD CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2023-2031 ($ MILLION)
  • 20.REST OF THE WORLD CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY SERVICE PROVIDER, 2023-2031 ($ MILLION)

LIST OF FIGURES

  • 1.GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2023 VS 2031 (%)
  • 2.GLOBAL EVENT MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 3.GLOBAL CONTINUOUS RHYTHM MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 4.GLOBAL HOLTER MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 5.GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY SERVICE PROVIDER, 2023 VS 2031 (%)
  • 6.GLOBAL MOBILE CARDIAC TELEMETRY MONITORING SERVICE PROVIDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 7.GLOBAL INDEPENDENT DIAGNOSTIC TESTING FACILITIES/CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 8.GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
  • 9.US CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 10.CANADA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 11.UK CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 12.FRANCE CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 13.GERMANY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 14.ITALY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 15.SPAIN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 16.REST OF EUROPE CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 17.INDIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 18.CHINA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 19.JAPAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 20.SOUTH KOREA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 21.REST OF ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 22.LATIN AMERICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
  • 23.THE MIDDLE EAST AND AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)